Blogs

FDA Approves New Anti-Infective Combination for cIAI The FDA approved aztreonam and avibactam (EMBLAVEO™, Abbvie) as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination antibiotic. It is approved in combination with metronidazole, for patients 18 years and older who have limited or no alternative options for the treatment of complicated intra-abdominal infections (cIAI), including those caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae complex, Citrobacter freundii complex, and Serratia marcescens. Read the announcement ...

CMS Working With DOGE CMS announced that it has assigned 2 industry veterans to lead its collaboration with the Department of Government Efficiency (DOGE), including ensuring appropriate access to CMS systems and technology. “We are taking a thoughtful approach to see where there may be opportunities for more effective and efficient use of resources in line with meeting the goals of President Trump,” said the agency. Read the announcement . Tell Us What You Think About INFUSION Magazine NHIA is looking for feedback and reader impressions of INFUSION magazine. Please take a short survey and share your opinions on this member service. ...

You can use the NHIA Community to participate in online forums across the full NHIA membership or within topic-specific communities. You can also search for and direct message other members, stay up to date on upcoming events and opportunities for participation in research or advocacy, and access NHIA member resources. Check out the brief video below on how to get started by updating your profile, joining communities and participating in discussions. Connect directly with other NHIA members by using the directory or visiting their profile and adding them as a contact. You'll be able to send them a direct message by clicking on the dots beneath their title. ...